🇺🇸 Estradiol Transdermal in United States

FDA authorised Estradiol Transdermal on 22 December 1994

Marketing authorisations

FDA — authorised 22 December 1994

  • Application: NDA020375
  • Marketing authorisation holder: BAYER HLTHCARE
  • Status: supplemented

FDA

  • Status: approved

Estradiol Transdermal in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Estradiol Transdermal approved in United States?

Yes. FDA authorised it on 22 December 1994; FDA has authorised it.

Who is the marketing authorisation holder for Estradiol Transdermal in United States?

BAYER HLTHCARE holds the US marketing authorisation.